These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24120854)

  • 1. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.
    Maishi N; Sakurai Y; Hatakeyama H; Umeyama Y; Nakamura T; Endo R; Alam MT; Li C; Annan DA; Kikuchi H; Morimoto H; Morimoto M; Akiyama K; Ohga N; Hida Y; Harashima H; Hida K
    Cancer Sci; 2022 May; 113(5):1855-1867. PubMed ID: 35266253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomas.
    Sakurai Y; Hatakeyama H; Akita H; Harashima H
    Mol Pharm; 2014 Aug; 11(8):2713-9. PubMed ID: 24800640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of a Cyclic RGD: Modified Liposomal SiRNA Formulation for Use in Active Targeting to Tumor and Tumor Endothelial Cells.
    Sakurai Y; Hada T; Harashima H
    Methods Mol Biol; 2016; 1364():63-9. PubMed ID: 26472442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Harashima H
    Mol Ther; 2013 Jun; 21(6):1195-203. PubMed ID: 23568259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device].
    Sakurai Y
    Yakugaku Zasshi; 2019; 139(11):1357-1363. PubMed ID: 31685731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting tumor growth by targeting liposomally encapsulated CDC20siRNA to tumor vasculature: therapeutic RNA interference.
    Majumder P; Bhunia S; Bhattacharyya J; Chaudhuri A
    J Control Release; 2014 Apr; 180():100-8. PubMed ID: 24556418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA.
    Liu X; Wang W; Samarsky D; Liu L; Xu Q; Zhang W; Zhu G; Wu P; Zuo X; Deng H; Zhang J; Wu Z; Chen X; Zhao L; Qiu Z; Zhang Z; Zeng Q; Yang W; Zhang B; Ji A
    Nucleic Acids Res; 2014 Oct; 42(18):11805-17. PubMed ID: 25223783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells.
    Hada T; Sakurai Y; Harashima H
    Pharmaceutics; 2015 Sep; 7(3):320-33. PubMed ID: 26389942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
    Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
    Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
    Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
    Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas.
    Amin M; Badiee A; Jaafari MR
    Int J Pharm; 2013 Dec; 458(2):324-33. PubMed ID: 24148663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor.
    Mondal G; Barui S; Chaudhuri A
    Biomaterials; 2013 Aug; 34(26):6249-60. PubMed ID: 23702147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
    Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
    Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes.
    Sakurai Y; Matsuda T; Hada T; Harashima H
    Biol Pharm Bull; 2015; 38(8):1185-91. PubMed ID: 26235581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
    Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
    Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
    Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.